MEMORIAL SLOAN-KETTERING CANCER CENTER

Memorial Sloan-Kettering Cancer Center provides specialized analytical services focused on genomic data interpretation, particularly in the context of cancer research and precision medicine. Based on award descriptions, the organization conducts advanced DNA sample analysis, leveraging high-throughput sequencing technologies and bioinformatics pipelines to extract clinically actionable insights from complex genomic datasets. Their technical expertise centers on heterogeneous tumor DNA characterization, variant calling, and molecular profiling—critical functions in oncology research and therapeutic development. The center’s differentiation lies in its deep integration of clinical oncology knowledge with cutting-edge laboratory and computational methods, enabling highly accurate, biologically grounded analysis of genetic alterations in cancer specimens. The organization has demonstrated direct engagement with the Department of Health and Human Services, delivering research-support services aligned with public health and biomedical innovation goals. This relationship suggests a focus on federally funded cancer research initiatives, likely supporting programs under the National Institutes of Health or Centers for Disease Control and Prevention that require rigorous genomic data processing and interpretation. The primary NAICS classification of 561110—Office Administrative Services—reflects the administrative and operational framework under which these technical services are delivered, rather than the nature of the work itself. In practice, this indicates the center operates as a research service provider, offering specialized scientific analysis under federal contract mechanisms typically managed through administrative support structures. Memorial Sloan-Kettering Cancer Center is structured as a non-federal entity with no active government certifications listed. Located in New York, NY, it leverages its institutional reputation and scientific infrastructure to serve federal research priorities, positioning itself as a high-caliber provider of oncology-specific analytical services within the biomedical contracting landscape.